His primary areas of investigation include Surgery, Internal medicine, Multiple myeloma, Transplantation and Chemotherapy. His Surgery study deals with Aspergillosis intersecting with Lung, Respiratory disease and Amphotericin B. Denis Caillot has researched Internal medicine in several fields, including Gastroenterology and Oncology.
His biological study spans a wide range of topics, including Hematopoietic stem cell transplantation and Pathology. In his research on the topic of Multiple myeloma, Survival analysis is strongly related with Urology. His studies deal with areas such as Myeloid leukemia and Maintenance therapy as well as Transplantation.
His main research concerns Internal medicine, Multiple myeloma, Surgery, Oncology and Transplantation. Denis Caillot works mostly in the field of Internal medicine, limiting it down to topics relating to Gastroenterology and, in certain cases, Immunology. His Multiple myeloma research is multidisciplinary, incorporating perspectives in Newly diagnosed and Dexamethasone.
He works mostly in the field of Surgery, limiting it down to concerns involving Aspergillosis and, occasionally, Mycosis. His study looks at the relationship between Oncology and fields such as Myeloid leukemia, as well as how they intersect with chemical problems. His Transplantation study combines topics in areas such as Retrospective cohort study and Bone marrow, Minimal residual disease.
Internal medicine, Oncology, Multiple myeloma, Newly diagnosed and Dexamethasone are his primary areas of study. His research on Internal medicine often connects related areas such as Stem cell. His work deals with themes such as Hematopoietic stem cell transplantation, Cyclophosphamide, Chemotherapy, Myeloid leukemia and Hazard ratio, which intersect with Oncology.
Many of his research projects under Multiple myeloma are closely connected to In patient with In patient, tying the diverse disciplines of science together. His Autologous stem-cell transplantation research also works with subjects such as
Denis Caillot mainly investigates Internal medicine, Multiple myeloma, Oncology, Transplantation and Thalidomide. His Internal medicine study frequently draws connections to other fields, such as Gastroenterology. His research in the fields of Bortezomib, Lenalidomide and Autologous stem-cell transplantation overlaps with other disciplines such as In patient and Text mining.
His work in Oncology tackles topics such as Gemtuzumab ozogamicin which are related to areas like Chemotherapy regimen. His studies in Transplantation integrate themes in fields like Positron emission tomography, Newly diagnosed, Standard technique and Blood pool. His Pomalidomide study in the realm of Thalidomide connects with subjects such as Standard treatment.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett.
The New England Journal of Medicine (2002)
Single versus Double Autologous Stem-Cell Transplantation for Multiple Myeloma
Michel Attal;Jean-Luc Harousseau;Thierry Facon;François Guilhot.
The New England Journal of Medicine (2003)
Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma
Michel Attal;Valerie Lauwers-Cances;Gerald Marit;Denis Caillot.
The New England Journal of Medicine (2012)
Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome
Hervé Avet-Loiseau;Michel Attal;Philippe Moreau;Catherine Charbonnel.
Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis
David W. Denning;Patricia Ribaud;Noel Milpied;Denis Caillot.
Clinical Infectious Diseases (2002)
Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery.
Denis Caillot;Olivier Casasnovas;Alain Bernard;Jean-Francois Couaillier.
Journal of Clinical Oncology (1997)
Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
Michel Attal;Valerie Lauwers-Cances;Cyrille Hulin;Xavier Leleu.
The New England Journal of Medicine (2017)
Maintenance therapy with thalidomide improves survival in patients with multiple myeloma
Michel Attal;Jean-Luc Harousseau;Serge Leyvraz;Chantal Doyen.
Increasing Volume and Changing Characteristics of Invasive Pulmonary Aspergillosis on Sequential Thoracic Computed Tomography Scans in Patients With Neutropenia
Denis Caillot;Jean-Francois Couaillier;Alain Bernard;Olivier Casasnovas.
Journal of Clinical Oncology (2001)
Bortezomib plus dexamethasone is superior to vincristine plus doxorubicin plus dexamethasone as induction treatment prior to autologous stem-cell transplantation in newly diagnosed multiple myeloma: results of the IFM 2005-01 phase III trial.
Jean-Luc Harousseau;Michel Attal;Hervé Avet-Loiseau;Gerald Marit.
Journal of Clinical Oncology (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: